041830 — InBody Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for InBody Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	137,837	160,004	170,351	204,465	233,948
Cost of Revenue
Gross Profit	101,320	121,072	132,455	158,226	181,010
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	101,985	119,306	132,003	167,726	197,196
Operating Profit	35,852	40,697	38,348	36,739	36,753
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	39,334	42,491	44,598	43,850	38,608
Provision for Income Taxes
Net Income After Taxes	33,982	33,826	36,561	32,707	29,988
Minority Interest
Net Income Before Extraordinary Items
Net Income	34,033	33,816	36,723	33,143	30,633
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	34,033	33,816	36,723	33,143	30,633
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2,590	2,598	2,811	2,555	2,419
Dividends per Share